These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26886653)

  • 1. Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival.
    Chang HJ; Chen PC; Yang CC; Su YC; Lee CC
    Medicine (Baltimore); 2016 Feb; 95(7):e2861. PubMed ID: 26886653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
    Yang CC; Fong Y; Lin LC; Que J; Ting WC; Chang CL; Wu HM; Ho CH; Wang JJ; Huang CI
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):235-240. PubMed ID: 29106506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery.
    Menendez ME; Neuhaus V; van Dijk CN; Ring D
    Clin Orthop Relat Res; 2014 Sep; 472(9):2878-86. PubMed ID: 24867450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality.
    Chu YT; Ng YY; Wu SC
    BMC Health Serv Res; 2010 May; 10():140. PubMed ID: 20507593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapting the Elixhauser comorbidity index for cancer patients.
    Mehta HB; Sura SD; Adhikari D; Andersen CR; Williams SB; Senagore AJ; Kuo YF; Goodwin JS
    Cancer; 2018 May; 124(9):2018-2025. PubMed ID: 29390174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data.
    Southern DA; Quan H; Ghali WA
    Med Care; 2004 Apr; 42(4):355-60. PubMed ID: 15076812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of seven comorbidity scores on four-month survival of lung cancer patients.
    Pluchart H; Bailly S; Chanoine S; Moro-Sibilot D; Bedouch P; Toffart AC
    BMC Med Res Methodol; 2023 Nov; 23(1):256. PubMed ID: 37923993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different comorbidity measures for oral cancer patients with surgical intervention: A longitudinal study from a single cancer center.
    Lee CC; Ho HC; Su YC; Chen PC; Yu CH; Yang CC
    Auris Nasus Larynx; 2016 Jun; 43(3):322-9. PubMed ID: 26642942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Performance of Comorbidity Measures in Predicting Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease.
    Zhan ZW; Chen YA; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():335-344. PubMed ID: 32103932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New ICD-10 version of the Multipurpose Australian Comorbidity Scoring System outperformed Charlson and Elixhauser comorbidities in an older population.
    Toson B; Harvey LA; Close JC
    J Clin Epidemiol; 2016 Nov; 79():62-69. PubMed ID: 27101889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases.
    Li B; Evans D; Faris P; Dean S; Quan H
    BMC Health Serv Res; 2008 Jan; 8():12. PubMed ID: 18194561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting In-Hospital Mortality in Elderly Patients With Cervical Spine Fractures: A Comparison of the Charlson and Elixhauser Comorbidity Measures.
    Menendez ME; Ring D; Harris MB; Cha TD
    Spine (Phila Pa 1976); 2015 Jun; 40(11):809-15. PubMed ID: 25785957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM-Coded Data Among Older Adults.
    Mehta HB; Li S; An H; Goodwin JS; Alexander GC; Segal JB
    Ann Intern Med; 2022 Oct; 175(10):1423-1430. PubMed ID: 36095314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Elixhauser and Charlson Methods for Discriminative Performance in Mortality Risk in Patients with Schizophrenic Disorders.
    Tsai KY; Hsieh KY; Ou SY; Chou FH; Chou YM
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32260241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Charlson and Elixhauser scores with varying lookback predicated mortality better than using individual scores.
    Pritchard E; Fawcett N; Quan TP; Crook D; Peto TE; Walker AS
    J Clin Epidemiol; 2021 Feb; 130():32-41. PubMed ID: 33002637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease-specific comorbidity index for predicting mortality in patients admitted to hospital with a cardiac condition.
    Azzalini L; Chabot-Blanchet M; Southern DA; Nozza A; Wilton SB; Graham MM; Gravel GM; Bluteau JP; Rouleau JL; Guertin MC; Jolicoeur EM
    CMAJ; 2019 Mar; 191(11):E299-E307. PubMed ID: 30885968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortality.
    Li P; Kim MM; Doshi JA
    BMC Health Serv Res; 2010 Aug; 10():245. PubMed ID: 20727154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions.
    Gutacker N; Bloor K; Cookson R
    Eur J Public Health; 2015 Feb; 25 Suppl 1():15-20. PubMed ID: 25690125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of the Charlson and Elixhauser Comorbidity Measures to Predict Inpatient Mortality After Proximal Humerus Fracture.
    Menendez ME; Ring D
    J Orthop Trauma; 2015 Nov; 29(11):488-93. PubMed ID: 26165266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple Excel and ICD-10 based dataset calculator for the Charlson and Elixhauser comorbidity indices.
    Prommik P; Tootsi K; Saluse T; Strauss E; Kolk H; Märtson A
    BMC Med Res Methodol; 2022 Jan; 22(1):4. PubMed ID: 34996364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.